Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Update

5 Feb 2018 07:14

RNS Number : 8852D
Electrocomponents PLC
05 February 2018
 

 

Electrocomponents plc today issues a trading update for the four-month period to 31 January 2018.

 

Underlying revenue growth(1)

Region

Q1 to June 2017

Q2 to Sept 2017

4 months to 31 Jan 2018

 

Northern Europe

 

10%

 

12%

13%

Southern Europe

10%

12%

11%

Central Europe

11%

14%

17%

Total Europe

10%

13%

13%

Asia Pacific

18%

17%

22%

The Americas

16%

15%

12%

Group

13%

14%

14%

 

Our strong underlying revenue (1) performance in H1 has continued into the first four months of H2. The market backdrop remains positive and we continue to execute well with improvements in areas such as customer experience, digital and sales effectiveness driving further market share gains.

· In the four months to 31 January 2018, Group underlying revenue growth remained strong at 14%, with all of our five regions continuing to see double-digit underlying revenue growth.

o Strong momentum in digital with 15% underlying revenue growth in the period reflecting success with our digital marketing strategy and improved online experience.

o A further acceleration in underlying revenue growth at RS Pro, our own-brand business, which grew at 14% during the period (+10% in H1).

· We remain on track to deliver stable gross margin for the full year to March 2018.

· At the end of this financial year we will have completed the first phase of the Performance Improvement Plan and delivered cumulative annualised savings of £30 million. We are currently examining new initiatives to further simplify the way we do business and generate efficiency.

 

Lindsley Ruth, Chief Executive Officer, commented

"Our performance year to date has been pleasing and we are confident of delivering strong progress in the current financial year. The first phase of the Performance Improvement Plan is now complete, but we still believe we have a significant further opportunity to improve efficiency and reduce complexity allowing continued strong growth at higher operating margins. We remain excited by the opportunity for growth and improvement."

 

LEI: 549300KVXDURRKVW7R37

 

Enquiries:

David Egan

Group Finance Director

0207 239 8400

Polly Elvin

Investor Relations and Corporate PR

0207 239 8427

Martin Robinson/David Allchurch

Tulchan Communications

0207 353 4200

 

Notes:

1. Revenue growth rates, unless otherwise stated, are adjusted for trading days and currency movements ("underlying revenue growth/decline").

2. During the year to March 2018 we expect to see around a £24 million adverse impact on revenue from fewer trading days compared with FY 2017. In the year to March 2019 we expect to see a positive impact of around £9 million on revenue from additional trading days compared with FY 2018.

3. Our profit remains sensitive to movements in exchange rates on translation of overseas profits. The average H1 exchange rates for Euro and US $ respectively were €1.14 and $1.29. Ten months to 31 January average spot rates for Euro and US $ respectively are €1.13 and $1.31. Assuming 31 January spot rates continue for the balance of the year our average exchange rates for Euro and US $ for the year would be €1.13 and $1.32. Every 1 cent movement in the Euro will have a circa £1.2 million impact on profit. Every 1 cent movement in US $ will have a circa £0.4 million impact on profit.

 

 

 

Electrocomponents plc - Conference Call Dial in Instructions

Date:

Monday 5 February

UK Time:

08.00h call

Telephone number:

+44 (0) 1452 541003

PIN:

9377237

Chairman:

Lindsley Ruth

Electrocomponents plc - Replay Dial in Instructions (available until Monday 12 February)

Telephone number:

+44 (0) 1452 550000

PIN:

9377237

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVABRWAAURRR
Date   Source Headline
28th Jun 202110:00 amRNSNotice of Trading Update
25th Jun 20212:30 pmRNSDirector/PDMR Shareholding
17th Jun 202111:00 amRNSDirector/PDMR Shareholding
15th Jun 202112:00 pmRNSAnnual Financial Report
10th Jun 202111:00 amRNSDirector/PDMR Shareholding
1st Jun 20219:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSFinal Results
24th May 20213:00 pmRNSHolding(s) in Company
4th May 20213:00 pmRNSDirector Declaration
4th May 20219:00 amRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20219:00 amRNSTotal Voting Rights
30th Mar 202110:00 amRNSNotice of Trading Update
18th Mar 20212:30 pmRNSDirector/PDMR Shareholding
10th Mar 202110:00 amRNSAdditional Listing
1st Mar 20214:00 pmRNSDirector Declaration
1st Mar 202110:00 amRNSTotal Voting Rights
1st Mar 20217:00 amRNSAcquisition of John Liscombe Limited
8th Feb 20217:00 amRNSTrading Statement
4th Feb 202110:00 amRNSHolding(s) in Company
2nd Feb 20212:30 pmRNSDirector/PDMR Shareholding
1st Feb 20219:01 amRNSBlock listing Interim Review
1st Feb 20219:00 amRNSTotal Voting Rights
27th Jan 202110:00 amRNSNotice of Trading Update
13th Jan 20217:00 amRNSCompletion of Synovos acquisition
4th Jan 202110:46 amRNSTotal Voting Rights
21st Dec 20202:30 pmRNSDirector/PDMR Shareholding
16th Dec 20209:30 amRNSHolding(s) in Company
15th Dec 20202:35 pmRNSHolding(s) in Company
11th Dec 202011:00 amRNSDirectorate Change
10th Dec 20204:17 pmRNSResults of the Placing
10th Dec 20207:20 amRNSRetail Offer via PrimaryBid.com
10th Dec 20207:18 amRNSProposed Placing of Ordinary Shares
10th Dec 20207:14 amRNSStrategically Attractive Acquisitions and Placing
4th Dec 202010:00 amRNSHolding(s) in Company
3rd Dec 20204:05 pmRNSHolding(s) in Company
1st Dec 202010:00 amRNSTotal Voting Rights
20th Nov 202010:30 amRNSDirector/PDMR Shareholding
20th Nov 202010:30 amRNSRefinancing of Group Debt facilities
17th Nov 20203:25 pmRNSHolding(s) in Company
17th Nov 20202:30 pmRNSAdditional Listing
12th Nov 202011:28 amRNSDirector/PDMR Shareholding
10th Nov 202010:00 amRNSDividend Declaration
10th Nov 20207:00 amRNSHalf-year Report
2nd Nov 202010:30 amRNSTotal Voting Rights
8th Oct 20207:00 amRNSTrading Statement
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 202010:00 amRNSTotal Voting Rights
21st Sep 202010:30 amRNSNotice of Trading Update
18th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.